PubMed Health treatment related to Long Qt Syndrome: 62
The goal of treating long QT syndrome (LQTS) is to prevent life-threatening, abnormal heart rhythms and fainting spells. Treatment isn't a cure for the disorder and may not restore a normal QT interval on an EKG (electrocardiogram ). However, treatment greatly improves the chances of survival.
Drugs for Long Qt Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 152)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Prednisone |
Approved, Vet_approved |
Phase 4 |
|
53-03-2 |
5865 |
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17a,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17α,21-diol-3,11,20-trione
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
Acis brand OF prednisone
ACon0_000082
ACon1_000297
Acsis, prednison
Adasone
AI3-52939
Ancortone
Apo-prednisone
Apo-Prednisone
Apotex brand OF prednisone
Aventis brand OF prednisone
Betapar
Bicortone
Bio-0649
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
C07370
C21H26O5
Cartancyl
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
CPD001227202
Cutason
Dacorten
Dacortin
DB00635
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
delta cortelan
Delta Cortelan
Delta E
Delta E.
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
Delta-cortelan
Delta-Cortelan
Deltacortene
delta-Cortisone
Deltacortisone
Delta-cortisone
delta-Cortone
Deltacortone
Delta-cortone
Delta-dome
Delta-Dome
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Diadreson
Di-Adreson
Diba brand OF prednisone
Econosone
EINECS 200-160-3
Encorton
Encortone
Enkortolon
Enkorton
Fawns and mcallan brand OF prednisone
Fernisone
Ferring brand OF prednisone
Fiasone
GALENpharma brand OF prednisone
Halsey drug brand OF prednisone
Hexal brand OF prednisone
HMS1568O15
HMS2090J13
|
Hoechst brand OF prednisone
Hostacortin
HSDB 3168
ICN brand OF prednisone
Incocortyl
In-Sone
Juvason
Kortancyl
Lichtenstein brand OF prednisone
Liquid pred
Liquid Pred
Lisacort
LMST02030180
Lodotra
LS-1325
MEGxm0_000443
Me-Korti
Merck brand OF prednisone
Merz brand OF prednisone
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
Mibe brand OF prednisone
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI60_000008
NCI-C04897
Nisona
Nizon
Novoprednisone
NSC 10023
NSC10023
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Pharmacia brand OF prednisone
PRD
Precort
Predeltin
Predni tablinen
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Predniment
Prednison
Prednison acsis
Prednison galen
Prednison hexal
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone [INN:BAN]
Prednisone Intensol
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick_405
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
Schering-plough brand OF prednisone
Seatrace brand OF prednisone
Servisone
SK-Prednisone
SMR000718760
SMR001227202
Solvay brand OF prednisone
Sone
SPBio_002214
Sterapred
Supercortil
Trommsdorff brand OF prednisone
U 6020
Ultracorten
Ultracortene
UNII-VB0R961HZT
Winpred
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Wojtab
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
ZINC03875357
|
|
2 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
Aresol
Benylin-e
Breonesin
Bronchol
Ether, guaiacol glyceryl
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
|
Glycerylguaiacol
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
Guaifenesina
Guaifenesine
guaiphenesin
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
Humibid
Hustosil
Hytuss
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
O-Methoxyphenyl glyceryl ether
Organidin NR
p-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
|
|
3 |
|
Methadone |
Approved |
Phase 4 |
|
76-99-3 |
4095 |
Synonyms:
(-)-(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(-)-Methadone
(+)-Methadone
(+-)-Methadone
(+/-)-methadone
(+/-)-Methadone
(+/-)-methadone hydrochloride
(+/-)-Methadone hydrochloride
(+/-)-Tussal
(±)-methadone
(6R)-Methadone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-hetpanone
(S)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
1095-90-5 (hydrochloride)
297-88-1
3-14-00-00278 (Beilstein Handbook Reference)
3-14-00-00279 (Beilstein Handbook Reference)
3-Hetpanone, 6-(dimethylamino)-4,4-diphenyl-, (R)- (9CI)
5653-80-5
6-(Dimethylamino)-4,4-diphenyl-3-heptanone dl-mixture
6-(dimethylamino)-4,4-diphenylheptan-3-one
6-dimethylamino-4,4-di(phenyl)heptan-3-one
6-Dimethylamino-4,4-diphenyl-3-heptanone
6S-Methadone
76-99-3
A 4624
AC-16055
AC1L1HEG
AC1Q2RLW
Adanon
Adanon hydrochloride
AddiCare brand OF methadone hydrochloride
Adolan
Algidon
Algolysin
Algovetin
Althose
Althose hydrochloride
Amidon
Amidone
AN 148
AN-148 (*Hydrochloride*)
Biodone
Biomet brand OF methadone hydrochloride
Biscuits
BRN 3213667
BRN 3213668
BRN 3213669
Butalgin
C07163
CHEBI:6807
CHEMBL651
CID4095
D08195
d-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
DB00333
DEA No. 9250
Depridol
Dextromethadone
Diaminon
Diaminon hydrochloride
DivK1c_000963
dl-Methadone
DL-Methadone
DL-Methadone hydrochloride
d-Methadone
Dollies
Dolly
Dolofin hydrochloride
Dolohepton
Dolophin
Dolophin hydrochloride
Dolophine
Dolophine (*Hydrochloride*)
Dolophine HCL
EINECS 200-996-9
Esteve brand OF methadone hydrochloride
Fenadon
Fenadone
Fenadone (*Hydrochloride*)
Generics brand OF methadone hydrochloride
GlaxoSmithKline brand OF methadone hydrochloride
Heptadon
|
Heptadone
Heptadone (*Hydrochloride*)
Heptanon
Heptanon (*Hydrochloride*)
Heptanon (pharmaceutical)
Hoechst 10820
Hoescht 10820 (*Hydrochloride*)
HSDB 3119
Hydrochloride, methadone
IDI1_000963
K 174
KBio1_000963
Ketalgin
Ketalgin hydrochloride
L-(+)-Methadone
L000874
L-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
Levometadona
Levometadona [INN-Spanish]
Levomethadone [INN]
Levomethadonum
Levomethadonum [INN-Latin]
Levothyl
l-Methadone
L-Polamidon
l-Polamivet
LS-74485
LS-74486
LS-74487
Mallinckrodt brand OF methadone hydrochloride
Martindale brand OF methadone hydrochloride
Mecodin
Mephenon
Metadol
Metadona
Metadona [INN-Spanish]
Metadona [Spanish]
Metadone
Metadone [DCIT]
Metasedin
Methaddict
Methadon
Methadona
Methadona [Spanish]
methadone
Methadone
Methadone (BAN)
Methadone [INN:BAN]
Methadone HCL
Methadone HCL Intensol
Methadone hydrochloride
Methadone M
Methadonum
Methadonum [INN-Latin]
Methadonum [Latin]
Methadose
Methaquaione
Methex
Miadone
Moheptan
MolPort-001-785-650
NINDS_000963
Pharmascience brand OF methadone hydrochloride
Phenadone
Phenadone (*Hydrochloride*)
Phenadone hydrochloride
Phymet
Physeptone
Pinadone
Pinewood brand OF methadone hydrochloride
Polamidon
Polamidone
Polamivet
Racemic methadone
Rosemont brand OF methadone hydrochloride
Roxane brand OF methadone hydrochloride
S-(+)-Methadone
Sedo-Rapide
Symoron
Tussol
UNII-UC6VBE7V1Z
Westadone
Yamanouchi brand OF methadone hydrochloride
|
|
4 |
|
Hydromorphone |
Approved, Illicit |
Phase 4 |
|
466-99-9 |
5284570 |
Synonyms:
(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one
(-)-(5R)-4,5-Epoxy-3-hydroxy-9a-methylmorphinan-6-one
(-)-(5R)-4,5-Epoxy-3-hydroxy-9α-methylmorphinan-6-one
(-)-Hydromorphone
(5alpha)-3-hydroxy-17-methyl-4,5-epoxymorphinan-6-one
18145-12-5
3-hydroxy-17-methyl-4,5alpha-epoxymorphinan-6-one
4,5a-Epoxy-3-hydroxy-17-methyl-6-morphinanone
4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone
4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one
4,5Α-epoxy-3-hydroxy-17-methyl-6-morphinanone
41376-02-7
466-99-9
6-Deoxy-7,8-dihydro-6-oxomorphine
7,8-Dihydromorphinone
C07042
CHEBI:5790
CHEMBL398707
CID5284570
D08047
DB00327
DEA No. 9150
Dihydromorfinon
Dihydromorfinon [Czech]
Dihydromorphinone
Dilaudid
Dilaudid Oros
Dilaudid-hp
DiMo
Dimorphone
EINECS 207-383-5
|
Hidromorfona
Hidromorfona [INN-Spanish]
HSDB 3341
Hydromorfona
Hydromorfona [Spanish]
Hydromorphon
hydromorphone
Hydromorphone
Hydromorphone (INN)
Hydromorphone [INN:BAN]
Hydromorphone HCL
Hydromorphone hydrochloride
Hydromorphonum
Hydromorphonum [INN-Latin]
Hymorphan
Idromorfone
Idromorfone [DCIT]
Laudacon
Laudicon
LS-187185
LS-92152
MolPort-004-285-951
Morphinan-6-one, 4,5alpha-epoxy-3-hydroxy-17-methyl- (8CI)
Novolaudon
NSC 19046
NSC19046
Palladone
Paramorphan
UNII-Q812464R06
WLN: T B6566 B6/CO 4ABBC R BX FV HO PN GHT&&TTJ JQ P1
|
|
5 |
|
Testosterone undecanoate |
Approved, Investigational |
Phase 4 |
|
5949-44-0 |
|
Synonyms:
Testosterone undecanoate
Testosterone undeconate
|
|
|
6 |
|
Testosterone enanthate |
Approved |
Phase 4 |
|
315-37-7 |
9416 |
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
17beta-Hydroxyandrost-4-en-3-one heptanoate
17beta-Hydroxyandrost-4-en-3-one heptanoic acid
17b-Hydroxyandrost-4-en-3-one heptanoate
17b-Hydroxyandrost-4-en-3-one heptanoic acid
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17Î’-hydroxyandrost-4-en-3-one heptanoate
17Î’-hydroxyandrost-4-en-3-one heptanoic acid
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn l.a.
Andropository
Androtardyl
Atlatest
BTG Brand OF testosterone enanthate
DEA no. 4000
Delatest
Delatestryl
DePatestrye
Depo-testro med
Ditate
Durathate
Eifelfango brand OF testosterone enanthate
Everone
Exten test
Jenapharm brand OF testosterone enanthate
Malogen l.a.
Malogen l.a.200
Orquisteron-e
Pasadena brand OF testosterone enanthate
|
Primoteston depot
Primotestone
Reposo TMD
Roberts brand OF testosterone enanthate
Rotexmedica brand OF testosterone enanthate
Rugby brand OF testosterone enanthate
Schering brand OF testosterone enanthate
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosteron depot-rotexmedica
Testosteron-depot eifelfango
Testosteron-depot jenapharm
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone 17-enanthate
Testosterone 17-enanthic acid
Testosterone enantate
Testosterone enanthic acid
Testosterone heptanoate
Testosterone heptanoic acid
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
Testrin p.a.
Theramed brand OF testosterone enanthate
Theramex
|
|
7 |
|
Testosterone |
Approved, Investigational |
Phase 4 |
|
58-22-0 |
6013 |
Synonyms:
(+-)-8-iso-Testosterone
(+-)-Retrotestosterone
(+)-Testosterone
(+-)-Testosterone
(17b)-17-Hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-iso-Testosterone
17 beta Hydroxy 4 androsten 3 one
17 beta Hydroxy 8 alpha 4 androsten 3 one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-hydroxy-4-androsten-3-one
17beta-Hydroxy-4-androsten-3-one
17-beta-Hydroxy-4-androsten-3-one
17-beta-Hydroxy-8 alpha-4-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17-beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-hydroxy-4-androsten-3-one
17b-Hydroxy-4-androsten-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-androst-4-en-3-ON
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Testosterone
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-androst-4-en-3-one
17-Hydroxy-D4-androsten-3-one
17Î’-hydroxy-4-androsten-3-one
46923_FLUKA
46923_RIEDEL
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-17b-ol-3-one
4-androsten-17β-ol-3-one
4-Androsten-17β-ol-3-one
4-Androsten-3-one-17b-ol
4-androstene-17beta-ol-3-one
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8 Isotestosterone
8-iso-Testosterone
8-Isotestosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
Androderm
Androderm (TN)
Androgel
AndroGel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17beta-ol-3-one
Androst-4-en-17b-ol-3-one
Androst-4-ene-17b-ol-3-one
Androtop
Andrusol
Andryl 200
AstraZeneca brand OF testosterone
Auxilium pharmaceuticals inc. brand OF testosterone
Axiron
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
Bartor brand OF testosterone
beta testosterone
Beta Testosterone
BIDD:ER0555
BIM-0061761.0001
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CEPA brand OF testosterone
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
Depotest
Depo-Testosterone
Depo-Testosterone Cypionate
Dr. kade brand OF testosterone
EINECS 200-370-5
Epitestosteron
Everone 200
Faulding brand OF testosterone
Ferring brand OF testosterone
geno-Cristaux gremy
Geno-cristaux gremy
Geno-Cristaux Gremy
GlaxoSmithKline brand OF testosterone
|
Halotensin
Hauck brand OF testosterone
Histerone
HMS2052N11
Homosteron
Homosterone
HSDB 3398
Intrinsa
Libigel
LibiGel
LMST02020002
LS-148813
Lumitestosteron
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, aquaspension injection
Malogen, Aquaspension Injection
Mertestate
Metandren
Methyltestosterone
MLS000563091
MLS001032098
MLS001306401
MLS002174283
MolPort-002-506-901
NCGC00091018-01
Neo-Hombreol F
Neotestis
Neo-testis
Neo-Testis
NSC 9700
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
ortho Brand OF testosterone
Paladin brand OF testosterone
Pasadena brand OF testosterone
Perandren
Percutacrine androgenique
Percutacrine Androgenique
Primotest
Primoteston
rac-17b-Hydroxy-(13a)androst-4-en-3-one
rac-17b-Hydroxy-(8a)-androst-4-en-3-one
rac-17b-Hydroxy-(9b,10a)androst-4-en-3-one
rac-17b-Hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
Scheinpharm Testone-Cyp
Schering brand OF testosterone
SmithKline beecham brand OF testosterone
SMR000058344
SMR001261453
Solvay brand OF testosterone
Sterotate
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
T-Cypionate
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
testosterone
Testosterone
Testostérone
Testosterone (JAN/USP)
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone Cypionate
Testosterone Enanthate
Testosterone hydrate
Testosterone Hydrate
Testosterone solution
Testosterone sulfate
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testoviron
Testoviron schering
Testoviron Schering
Testoviron T
Testred
Testred Cypionate 200
Testrin-P.A
testro AQ
Testro Aq
Testro AQ
Testrone
Testryl
Tostrelle
Tostrex
trans-Testosterone
Trans-Testosterone
Ulmer brand OF testosterone
UNII-3XMK78S47O
Unimed brand OF testosterone
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
Watson brand OF testosterone
ZINC06500184
|
|
8 |
|
Progesterone |
Approved, Vet_approved |
Phase 4 |
|
57-83-0 |
5994 |
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17alpha-progesterone
17alpha-Progesterone
17a-Progesterone
17α-progesterone
17Α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
46665_FLUKA
46665_RIEDEL
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC1L1LKF
AC-700
Agolutin
AI3-51682
Akrolutin
Amen
BB_NC-0185
beta-Progesterone
BHR-100
BIDD:ER0547
BIDD:PXR0094
Bio-luton
Bio-Luton
bmse000482
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
Colprosterone
component of Cyclogesterin
Corlutin
Corlutina
Corluvite
Corporin
corpus luteum hormone
Corpus luteum hormone
Corpus Luteum Hormone
CPD000058345
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
Cycrin
D00066
D4-Pregnene-3,20-dione
DB00396
Delalutin
delta(4)-Pregnene-3,20-dione
Delta(4)-pregnene-3,20-dione
Delta(4)-Pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta4-Pregnene-3,20-dione
DR-2011
Duraprogen
EINECS 200-350-6
Endometrin
Estima
ETI-411
EU-0100895
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gelbkörperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
Hormoflaveine
Hormoluton
HSDB 3389
Hydroxyprogesterone caproate
Hydroxyprogesterone caproic acid
Lingusorbs
Lipolutin
Lipo-lutin
Lipo-Lutin
LMST02030159
Lopac0_000895
LS-234
Lucorteum
Lucorteum sol
Lucorteum Sol
Lugesteron
Luteal hormone
Luteal Hormone
Luteinique
Luteocrin normale
Luteocrin Normale
Luteodyn
Luteogan
luteohormone
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
|
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin m
Lutocuclin M
Lutocyclin
Lutocyclin m
Lutocyclin M
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
Membrettes
Methylpregnone
Micronized Progesterone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MolPort-001-794-643
MPA
Nalutron
Natural Progesterone
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
nchembio.2007.53-comp14
NCI60_042166
NSC 64377
NSC 9704
NSC64377
NSC9704
NSC-9704
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
Percutacrine
Percutacrine luteinique
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick_411
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
PROGESTERONE
Progestérone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, (13 alpha,17 alpha)-(+-)-isomer
Progesterone, (17 alpha)-isomer
Progesterone, (9 beta,10 alpha)-isomer
Progesterone, water-soluble
Progesterone: HBC complex
Progesterone-Water Soluble
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
Spectrum5_002053
SR-01000000088
SR-01000000088-5
Syngesterone
Syngestrets
Synovex S
Syntolutan
Thiuram E
Thiuranide
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
Δ(4)-pregnene-3,20-dione
|
|
9 |
|
Ibutilide |
Approved |
Phase 4 |
|
122647-31-8, 122647-32-9 |
60753 |
Synonyms:
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfoanilide (E)-2-butenedioate (2:1)
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfonanilide fumarate (2:1) (salt)
(+-)-N-(4-(4-(Ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide (E)-butenedioate
(E)-but-2-enedioic acid
122647-31-8
122647-31-8 (Parent)
122647-32-9
122647-32-9 (Fumarate)
130350-52-6
2C20H36N2O3S.C4H4O4
AC1L1TUW
AC1NQXZ2
AC1O5NJM
AC1Q6VUF
Butilide fumarate
C07753
C20H36N2O3S
CHEBI:112608
CHEMBL1200564
CHEMBL533
CID5281065
CID60753
CID6437366
Corvert
Corvert (TN)
D00648
D08060
DB00308
I06-1701
Ibutilid
Ibutilida
Ibutilida [INN-Spanish]
Ibutilide
Ibutilide (INN)
Ibutilide [BAN:INN]
|
Ibutilide [INN:BAN]
Ibutilide fumarate
IBUTILIDE FUMARATE
Ibutilide fumarate (USAN)
Ibutilide Fumarate [USAN]
Ibutilide, (-)-isomer
ibutilide, (+-)-isomer
Ibutilide, (+)-isomer
Ibutilide, (+-)-isomer
ibutilide, fumarate salt (2:1), (+-)-isomer
Ibutilide, fumarate salt (2:1), (+)-isomer
Ibutilide, fumarate salt (2:1), (+-)-isomer
Ibutilidum
Ibutilidum [INN-Latin]
LS-172765
LS-90123
LS-90124
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-, (E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-,(E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (E)-2-butenedioate (2:1) (salt)
MolPort-005-932-621
N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide
N-(4-(4-(Ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide
n-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide
N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide
N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide
NCGC00181771-01
U 70226E
U-70226E
U82208E
U-82208E
U82209E
U-82209E
UNII-2436VX1U9B
UNII-9L5X4M5L6I
|
|
10 |
|
Methyltestosterone |
Approved |
Phase 4 |
|
58-18-4 |
6010 |
Synonyms:
17 alpha Methyltestosterone
17 beta Hydroxy 17 methyl 4 androsten 3 one
17 beta Methyltestosterone
17 beta-Hydroxy-17-methyl-4-androsten-3-one
17 beta-Methyltestosterone
17 Epimethyltestosterone
17(a)-Methyl-delta(4)-androsten-17(b)-ol-3-one
17(a)-Methyl-δ(4)-androsten-17(b)-ol-3-one
17(alpha)-Methyl-Delta(4)-androsten-17(beta)-ol-3-one
17(Α)-methyl-δ(4)-androsten-17(β)-ol-3-one
17alpha Methyl testosterone
17alpha Methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-Delta(4)-androsten-17beta-ol-3-one
17alpha-Methyl-delta-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-Methyl-testosterone
17-alpha-Methyltestosterone
17a-Methyl-3-oxo-4-androsten-17b-ol
17a-Methyl-delta(4)-androsten-17b-ol-3-one
17a-Methyltestosterone
17a-Methyl-δ(4)-androsten-17b-ol-3-one
17beta Hydroxy 17 methyl 4 androsten 3 one
17beta Methyltestosterone
17beta-Hydroxy-17-methyl-4-androsten-3-one
17beta-Hydroxy-17-methylandrost-4-en-3-one
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17beta-Methyltestosterone
17b-Hydroxy-17-methylandrost-4-en-3-one
17-b-Hydroxy-17-methylandrost-4-en-3-one
17-Epimethyltestosterone
17-methyltestosterone
17-Methyltestosterone
17Α-methyl-3-oxo-4-androsten-17β-ol
|
17α-methyltestosterone
17Α-methyltestosterone
17Α-methyl-δ(4)-androsten-17β-ol-3-one
17α-methyl-Δ4-androsten-17β-ol-3-one
17Î’-hydroxy-17-methylandrost-4-en-3-one
17-Î’-hydroxy-17-methylandrost-4-en-3-one
4-Androstene-17alpha-methyl-17beta-ol-3-one
4-Androstene-17a-methyl-17b-ol-3-one
4-Androstene-17α-methyl-17β-ol-3-one
Android
Android 10
Android 25
Android 5
Android-10
Android-25
Android-5
Global pharmaceutical brand OF methyltestosterone
ICN brand 1 OF methyltestosterone
ICN brand 2 OF methyltestosterone
Mesteron
Mesterone
Metandren
Methitest
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Oreton
Schering brand OF methyltestosterone
Star brand OF methyltestosterone
Testoviron
Testred
Virilon
|
|
11 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
12 |
|
Analgesics |
|
Phase 4 |
|
|
|
13 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
14 |
|
glucocorticoids |
|
Phase 4 |
|
|
|
15 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4 |
|
|
|
16 |
|
Anesthetics |
|
Phase 4 |
|
|
|
17 |
|
Narcotics |
|
Phase 4 |
|
|
|
18 |
|
Antitussive Agents |
|
Phase 4 |
|
|
|
19 |
|
Analgesics, Opioid |
|
Phase 4 |
|
|
|
20 |
|
Chlorpheniramine, phenylpropanolamine drug combination |
|
Phase 4 |
|
|
|
21 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
22 |
|
Hormones |
|
Phase 4 |
|
|
|
23 |
|
Testosterone 17 beta-cypionate |
|
Phase 4 |
|
|
|
24 |
|
Progestins |
|
Phase 4 |
|
|
|
25 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
26 |
|
Androgens |
|
Phase 4 |
|
|
|
27 |
|
Ranolazine |
Approved, Investigational |
Phase 2 |
|
95635-55-5, 142387-99-3 |
56959 |
Synonyms:
( -)-Ranolazine
(-)-Ranolazine
142387-99-3
95635-55-5
AC-1673
AC1L1M17
AC1Q5LYD
BRD-A97674275-001-01-9
BSPBio_002276
CHEMBL1404
CID56959
CVT-303
D05700
DB00243
Dihydrochloride, ranolazine
HCL, Ranolazine
HMS1922F16
HMS2090L09
HMS2093D21
Hydrochloride, ranolazine
I01-2008
I06-0160
KEG-1295
Latixa
Lopac0_001062
LS-187267
MLS002154149
MolPort-003-666-653
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
|
N-(2,6-Dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide
NCGC00015897-05
NCGC00095177-01
NCGC00095177-02
NCGC00095177-03
RAN D
Ran4
Ranexa
Ranexa (TN)
Ranexa, Ranolazine
Ranolazina
ranolazine
Ranolazine
RANOLAZINE
Ranolazine (USAN/INN)
Ranolazine 2HCl
Ranolazine 2HCL
Ranolazine dihydrochloride
Ranolazine Dihydrochloride
Ranolazine HCL
Ranolazine hydrochloride
Renolazine
RS-43285
RS-43285-003
S1799_Selleck
SMR000857382
SPECTRUM1505366
UNII-A6IEZ5M406
|
|
28 |
|
Ivacaftor |
Approved |
Phase 2 |
|
873054-44-5 |
16220172 |
Synonyms:
ivacaftor
Ivacaftor
Ivacaftorum
Kalydeco
N-(2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
|
N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
vx-770
VX-770
|
|
29 |
|
Diuretics, Potassium Sparing |
|
Phase 2 |
|
|
|
30 |
|
Sodium Channel Blockers |
|
Phase 2 |
|
|
|
31 |
|
Moxifloxacin |
Approved, Investigational |
Phase 1 |
|
151096-09-2, 354812-41-2 |
152946 |
Synonyms:
(1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
151096-09-2
186826-86-8
192927-63-2
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
AC1L49EP
Actira
Actira (*Hydrochloride*)
Avalox
Avelox
Avelox (*Hydrochloride*)
Avelox I.V.
BAY 12-8039
BAY 12-8039 (*Hydrochloride*)
CCRIS 8690
|
CHEMBL32
CID152946
DB00218
I06-1961
Izilox
LS-141510
MFX
moxifloxacin
Moxifloxacin
Moxifloxacin [INN:BAN]
Moxifloxacin HCl
Moxifloxacin hydrochloride
Moxifloxacino
MXF
MXFX
Octegra
Proflox
UNII-U188XYD42P
Vigamox
|
|
32 |
|
Dofetilide |
Approved, Investigational |
Phase 1 |
|
115256-11-6 |
71329 |
Synonyms:
1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane
1-(4-Methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane
115256-11-6
1-MSPMPE
AC1L2FYH
AC1Q6VUS
AC-385
Ambap115256-11-6
b-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide
b-((p-Methanesulphonamidophenethyl)methylamino)methanesulphono-p-phenetidide
beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide
beta-((p-Methanesulphonamidophenethyl)methylamino)methanesulphono-p-phenetidide
C063533
C07751
C19H27N3O5S2
CHEBI:4681
CHEMBL473
CID71329
CPD000466333
D00647
DB00204
Dofetilida
Dofetilida [INN-Spanish]
Dofetilide
Dofetilide (JAN/USAN/INN)
Dofetilide [USAN:BAN:INN]
Dofetilidum
|
Dofetilidum [INN-Latin]
HMS2051N14
HMS2089F03
I06-0340
LS-90151
Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl)
MLS000759442
MLS001424185
MolPort-003-847-012
N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide
N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide
NCGC00164549-01
S1658_Selleck
SAM001246621
SMR000466333
Tikosyn
Tikosyn (TN)
Tikosyn, UK68798, Dofetilide
TL8000450
UK 68,798
UK 68798
UK-68,798
UK-68798
UNII-R4Z9X1N2ND
Xelide
Î’-((p-methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide
Î’-((p-methanesulphonamidophenethyl)methylamino)methanesulphono-p-phenetidide
|
|
33 |
|
Diltiazem |
Approved, Investigational |
Phase 1 |
|
42399-41-7 |
39186 |
Synonyms:
(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester
(+)-cis-5-[2-(Dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester
(+)-cis-5-[2-(Dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetic acid ester
(2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate
(2S,3S)-5-(2-(Dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate
(2S,3S)-5-(2-(Dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetic acid
(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
(2S,3S)-5-[2-(dimethylamino)ethyl]-2-[4-(methyloxy)phenyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
(2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
(2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
[(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate
144604-00-2
33286-22-5
42399-41-7
AC1L2181
AC1Q6LHX
AC-936
Acalix
Acetate (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Adizem
Aldizem
Altiazem
Anginyl
Angizem
Anoheal
Apo-Diltiaz
BIDD:GT0548
Bio1_000371
Bio1_000860
Bio1_001349
Biovail brand OF diltiazem hydrochloride
BPBio1_000230
BRD-K24023109-001-02-5
BRD-K24023109-003-03-9
Britiazim
BRN 3573079
Bruzem
BSPBio_000208
BSPBio_001311
C06958
C22H26N2O4S
Calcicard
Cardil
Cardizem
Cardizem (Hydrochloride)
Cardizem CD
Cardizem SR
Cardizen LA
Cartia XT
CHEBI:101278
CHEMBL23
CID39186
Citizem
Cormax
CRD 401
CRD-401
D07845
DB00343
d-cis-diltiazem
d-cis-Diltiazem
D-cis-Diltiazem
Deltazen
Dilacor
Dilacor XR
|
Dilacor-XR
Diladel
Dilcontin
Dilpral
Dilren
Dilrene
Dilta-Hexal
Dilt-cd
Diltia
diltiazem
Diltiazem
Diltiazem (INN)
Diltiazem [INN:BAN]
Diltiazem hydrochloride
Diltiazem malate
Diltiazemum
Diltiazemum [INN-Latin]
Dilticard
Diltzac
Dilzem
Dilzen
EINECS 255-796-4
Endrydil
FT-0081415
Herbesser
HMS1791B13
HMS1989B13
HMS2089H09
HSDB 6528
Incoril AP
Lopac0_000327
LS-40510
Masdil
MK-793 (Malate)
MolPort-002-509-369
NCGC00024309-02
NCGC00024309-04
NCGC00024309-05
NCGC00024309-06
NCGC00024309-07
NCGC00024309-08
NCGC00024309-09
NCGC00024309-10
nchembio.368-comp1
Novo-Diltazem
Nu-Diltiaz
Prestwick0_000134
Prestwick1_000134
Prestwick2_000134
Prestwick3_000134
RG 83606 (Hydrochloride)
SPBio_002147
STOCK1N-03672
Surazem
Surazem (TN)
Syn-Diltiazem
Tiamate
Tiazac
Tiazac Tildiem
Tiazac XC
Tocris-0685
UNII-EE92BBP03H
Viazem
Watson pharmaceuticals brand OF diltazem
|
|
34 |
|
Lidocaine |
Approved, Vet_approved |
Phase 1 |
|
137-58-6 |
3676 |
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
a-Diethylamino-2,6-dimethylacetanilide
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
AKOS001026768
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
Alphacaine
alpha-diethylamino-2,6-dimethylacetanilide
alpha-Diethylamino-2,6-dimethylacetanilide
Anestacon
Anestacon Jelly
ARONIS23855
Astrazeneca brand OF lidocaine
BIDD:GT0342
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
C07073
C14H22N2O
Cappicaine
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
Cito optadren
CPD000058189
Cuivasil
D00358
Dalcaine
DB00281
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jenapharm brand OF lidocanine hydrochloride
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L0156
L1026_SIGMA
L7757_SIGMA
Lanabiotic
L-Caine
Leostesin
Lida-Mantle
Lidocaina
|
Lidocaína
Lidocaina [INN-Spanish]
lidocaine
Lidocaine
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine [USAN:INN:JAN]
Lidocaine carbonate
Lidocaine Carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine Hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
Lidocaine Monohydrochloride
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
LIDOPEN
Lignocaine
Lignocainum
Lingocaine
Lopac0_000669
Lopac-L-5647
LQZ
LS-805
Maricaine
Maybridge1_002571
MLS000069724
MLS000758263
MLS001074177
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
nchembio.65-comp16
NINDS_000174
Norwood Sunburn Spray
Novocol brand OF lidocaine hydrochloride
NSC 40030
NSC40030
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
Solarcaine aloe extra burn relief cream
Solcain
SPBio_001525
SPBio_002100
Spectrum_001118
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
STK552033
Strathmann brand OF lidocaine hydrochloride
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
α-diethylamino-2,6-dimethylacetanilide
Α-diethylamino-2,6-dimethylacetanilide
|
|
35 |
|
Mexiletine |
Approved, Investigational |
Phase 1 |
|
31828-71-4 |
4178 |
Synonyms:
(+-)-1-(2,6-dimethylphenoxy)propan-2-amine
(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine
(±)-1-(2,6-dimethylphenoxy)propan-2-amine
(2Rs)-1-(2,6-Dimethylphenoxy)-2-aminopropane
(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane
1-(2',6'-dimethylphenoxy)-2-aminopropane
1-(2',6'-Dimethylphenoxy)-2-aminopropane
1-(2,6-dimethylphenoxy)-2-propanamine
1-(2,6-Dimethylphenoxy)-2-propanamine
1-(2,6-dimethylphenoxy)propan-2-amine
1-methyl-2-(2,6-xylyloxy)ethanamine
1-Methyl-2-(2,6-xylyloxy)ethanamine
1-Methyl-2-(2,6-xylyloxy)ethylamine
2-(2-aminopropoxy)-1,3-dimethylbenzene
2-(2-Aminopropoxy)-1,3-DiMethyl-Benzene Hydrochloride
31828-71-4
5370-01-4 (hydrochloride)
AB00053683
AC1L1HL7
AC1Q2BC5
AC1Q2BC6
Boehringer ingelheim brand OF mexiletine hydrochloride
BPBio1_000026
BRD-A64092382-003-04-3
BRN 2092205
BSPBio_000022
BSPBio_002254
C07220
CHEBI:115958
CHEBI:6916
CHEMBL558
CID4178
D08215
DB00379
DivK1c_000834
EINECS 250-825-7
I01-6374
IDI1_000834
KBio1_000834
KBio2_002082
KBio2_004650
KBio2_007218
|
KBio3_001474
KBioGR_001270
KBioSS_002082
KO1173
KO-1173
KOE-1173
Lopac0_000784
LS-68257
Mexiletene
Mexiletina
Mexiletina [INN-Spanish]
Mexiletine
Mexilétine
Mexiletine (INN)
Mexiletine [INN:BAN]
Mexiletine HCL
Mexiletine hydrochloride
Mexiletinum
Mexiletinum [INN-Latin]
Mexilitine
Mexitil
Mexitil PL
Mexityl
MolPort-001-790-944
NCGC00015659-04
NCGC00162253-01
NCGC00162253-02
NINDS_000834
Novo mexiletine
Novo-mexiletine
Novopharm brand OF mexiletine hydrochloride
Prestwick0_000241
Prestwick1_000241
Prestwick2_000241
Prestwick3_000241
SBB070242
SPBio_002241
Spectrum_001602
Spectrum3_000727
Spectrum4_000795
Spectrum5_001279
UNII-1U511HHV4Z
|
|
36 |
|
Verapamil |
Approved |
Phase 1 |
|
52-53-9 |
2520 |
Synonyms:
(+-)-Verapamil
(+/-)-VERAPAMIL
(1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile
2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
52-53-9
56949-77-0
AB00053495
AC-16016
AC1L1DV5
Akilen
alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile
alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile
Anpec
Apo-verap
Apo-Verap
Arpamyl
Arpamyl LP
Berkatens
Bio-0754
Bio1_000425
Bio1_000914
Bio1_001403
Bio2_000233
Bio2_000713
BPBio1_000268
BRD-A09533288-001-02-7
BRD-A09533288-003-05-6
BSPBio_000242
BSPBio_001513
BSPBio_002358
C07188
C27H38N2O4
Calan
Calan SR
Calaptin
Calaptin 240 SR
Calcan
Cardiabeltin
Cardiagutt
Cardibeltin
Cardioprotect
Caveril
CCRIS 6749
CHEBI:9948
CHEMBL6966
CID2520
Civicor
Civicor retard
cMAP_000023
Coraver
Cordilox
Cordilox SR
Corpamil
Covera-HS
CP-16533-1
CP-16533-1Calan
CP-165331Verapamil
D02356
D-365
D-365Iproveratril
DB00661
delta-365
Dexverapamil
Dignover
Dilacoran
Dilacoran hta
DivK1c_000399
Drosteakard
Durasoptin
EINECS 200-145-1
EINECS 260-462-6
Elthon
Falicard
Finoptin
Flamon
FT-0080127
Geangin
Harteze
Hexasoptin
Hexasoptin retard
HMS1791L15
HMS1989L15
HMS2089H17
Hormitol
Hydrochloride, verapamil
I06-0063
IDI1_000399
IDI1_033983
Ikacor
Ikapress
Inselon
Iproveratril
Isoptimo
Isoptin
Isoptin retard
Isoptin SR
Isoptine
Isoptino
Isotopin
Izoptin
Jenapamil
KBio1_000399
KBio2_000233
KBio2_002343
KBio2_002801
KBio2_004911
KBio2_005369
KBio2_007479
|
KBio3_000465
KBio3_000466
KBio3_002823
KBioGR_000233
KBioGR_001372
KBioGR_002343
KBioSS_000233
KBioSS_002346
L001330
Lekoptin
Lodixal
Lopac0_001237
LS-174
Magotiron
Manidon
Manidon retard
MolPort-000-721-258
NCGC00016083-14
NCGC00024710-04
NCGC00024710-05
NCGC00024710-06
NCGC00024710-07
NCGC00024710-08
NCGC00024710-09
nchembio.368-comp2
nchembio.79-comp5
NCI60_020143
NINDS_000399
Novapamyl LP
Novo-veramil
Novo-Veramil
NSC272366
Nu-verap
NU-Verap
Ormil
Praecicor
Prestwick0_000141
Prestwick1_000141
Prestwick2_000141
Prestwick3_000141
Quasar
Rapam
Robatelan
Sandoz brand OF verapamil
Securon
SPBio_001820
SPBio_002181
Spectrum2_001740
Spectrum4_000906
Spectrum5_001786
STK538085
Tarka
UNII-CJ0O37KU29
Univer
Univex
Vasolan
Vasomil
Vasopten
Verabeta
Veracaps SR
Veracim
Veracor
Verahexal
Veraloc
Veramex
Veramil
Verapamil
VERAPAMIL
Vérapamil
Verapamil (USAN/INN)
Verapamil [Usan:Ban:Inn]
Verapamil [USAN:BAN:INN]
Verapamil [USAN:INN:BAN]
Verapamil acis
Verapamil al
Verapamil atid
Verapamil basics
Verapamil ebewe
Verapamil HCl
Verapamil HCL
Verapamil henning
Verapamil hydrochloride
Verapamil injection
Verapamil MSD
Verapamil NM
Verapamil NM pharma
Verapamil nordic
Verapamil PB
Verapamil riker
Verapamil sandoz brand
Verapamil SR
Verapamil verla
Verapamil-abz
Verapamilo
Verapamilo [INN-Spanish]
Verapamilum
Verapamilum [INN-Latin]
Verapin
Verapress 240 SR
Veraptin
Verasal
Vera-sanorania
Verasifar
Veratensin
Verdilac
Verelan
Verelan PM
Verelan SR
Verexamil
Veroptinstada
Verpamil
Vetrimil
Vortac
|
|
37 |
|
Ritonavir |
Approved, Investigational |
Phase 1 |
|
155213-67-5 |
392622 |
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
538, ABT
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
A-84538
Abbott 84538
ABBOTT-84538
ABT 538
ABT 84538
ABT538
ABT-538
AC1L94GB
AC-733
AKOS000280930
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
DB00503
|
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
NSC693184
RIT
ritonavir
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
RTV
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
|
|
38 |
|
chloroquine |
Approved, Investigational, Vet_approved |
Phase 1 |
|
54-05-7 |
2719 |
Synonyms:
( -)-Chloroquine
(-)-Chloroquine
(+)-Chloroquine
(R)-(-)-Chloroquine
{4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine
3377 RP opalate
3545-67-3
50-63-5
54-05-7
56598-66-4
58175-86-3
58175-87-4
7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline
7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline
AB00053436
AC1L1EB8
AC1Q2ZA7
AC1Q2ZA8
Amokin
Aralen
Aralen HCl
Arechin
Arechine
Arequin
Arolen
Arthrochin
Artrichin
Avlochlor
Avloclor
Bemaco
Bemaphate
Bemaphic acid
Bemasulph
Benaquin
Bipiquin
BPBio1_000655
BRD-A91699651-065-01-1
BRN 0482809
BSPBio_000595
BSPBio_002001
C07625
C18H26ClN3
Capquin
CCRIS 3439
CHEBI:3638
CHEMBL76
Chemochin
Chingamin
Chloraquine
Chlorochin
Chlorochine
Chlorochinum
Chloroin
Chloroquin
Chloroquina
chloroquine
Chloroquine
Chloroquine (USP/INN)
Chloroquine (VAN)
Chloroquine [USAN:INN:BAN]
Chloroquine Bis-Phosphoric Acid
Chloroquine phosphate
Chloroquine Phosphate
Chloroquine sulfate
Chloroquine sulphate
Chloroquinium
Chloroquinum
Chloroquinum [INN-Latin]
Chlorquin
CID2719
Cidanchin
Clorochina
Clorochina [DCIT]
Cloroquina
Cloroquina [INN-Spanish]
Cocartrit
CQ
CU-01000012392-2
D02366
Dawaquin
DB00608
Delagil
Dichinalex
DivK1c_000404
EINECS 200-191-2
Elestol
Gontochin
Gontochin phosphate
Heliopar
HMS2090O03
HSDB 3029
Hydroxychloroquine Sulfate
IDI1_000404
Imagon
|
Ipsen 225
Iroquine
KBio1_000404
KBio2_000592
KBio2_003160
KBio2_005728
KBio3_001221
KBioGR_000778
KBioSS_000592
Khingamin
Klorokin
Lapaquin
Lopac0_000296
LS-141726
Malaquin
Malaquin (*Diphosphate*)
Malaren
Malarex
Mesylith
Miniquine
MolMap_000009
MolPort-001-783-623
N(4)-(7-Chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine
N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine
N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine
N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine
NCGC00015256-04
NCGC00162120-01
nchembio.215-comp4
nchembio.368-comp8
nchembio.87-comp17
NCI60_000894
Neochin
NINDS_000404
Nivachine
Nivaquine
Nivaquine b
Nivaquine B
NSC 187208
NSC14050
NSC187208
Pfizerquine
Plaquenil
Prestwick0_000548
Prestwick1_000548
Prestwick2_000548
Prestwick3_000548
Quinachlor
Quinagamin
Quinagamine
Quinercyl
Quingamine
Quinilon
Quinoscan
Resochen
Resochin
Resoquina
Resoquine
Reumachlor
Reumaquin
Rivoquine
Ro 01-6014/N2
Ronaquine
Roquine
RP 3377
RP-3377
Sanoquin
Silbesan
Siragan
SMP2_000034
SN 6718
SN-7618
Solprina
Sopaquin
SPBio_000174
SPBio_002516
Spectrum_000132
Spectrum2_000127
Spectrum3_000341
Spectrum4_000279
Spectrum5_000707
ST 21
ST 21 (pharmaceutical)
Sulfate, chloroquine
Sulphate, chloroquine
Tanakan
Tanakene
Tresochin
Trochin
UNII-886U3H6UFF
W 7618
WIN 244
WLN: T66 BNJ EMY1&3N2&2 IG
|
|
39 |
|
Lopinavir |
Approved |
Phase 1 |
|
192725-17-0 |
92727 |
Synonyms:
(1S-(1R*(R*),3R*,4R*))-N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
(alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide
1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI)
192725-17-0
1mui
2o4s
2q5k
2rkf
2rkg
378, ABT
A 157378
A 157378.0
A-157378.0
A-157378-0
AB1
ABT 157378
ABT 378
ABT-378
ABT-378, LOPINAVIR
ABT-378a-157378-0a-157378.0
AC1L3OPJ
AIDS032937
Aluviran
|
C12871
C37H48N4O5
CHEBI:40456
CHEMBL729
CID92727
D01425
DB01601
Kaletra
Koletra
Lopinavir
Lopinavir (JAN/USAN/INN)
Lopinavir [USAN:INN:BAN]
LPV
LS-173766
MolPort-003-848-410
N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide
N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide
N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE
NCGC00164576-01
NCGC00164576-02
RS-346
S1380_Selleck
UNII-2494G1JF75
|
|
40 |
|
Calcium, Dietary |
|
Phase 1 |
|
|
|
41 |
|
Anti-Bacterial Agents |
|
Phase 1 |
|
|
|
42 |
|
Antihypertensive Agents |
|
Phase 1 |
|
|
|
43 |
|
Vasodilator Agents |
|
Phase 1 |
|
|
|
44 |
|
Anti-Infective Agents |
|
Phase 1 |
|
|
|
45 |
|
Norgestimate, ethinyl estradiol drug combination |
|
Phase 1 |
|
|
|
46 |
|
Potassium Channel Blockers |
|
Phase 1 |
|
|
|
47 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 1 |
|
|
|
48 |
|
Antiparasitic Agents |
|
Phase 1 |
|
|
|
49 |
|
Antiprotozoal Agents |
|
Phase 1 |
|
|
|
50 |
|
Cytochrome P-450 CYP3A Inhibitors |
|
Phase 1 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 71)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes |
Completed |
NCT02513940 |
Phase 4 |
Testosterone;Progesterone;Placebo;Ibutilide |
2 |
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening: Reducing the Risk of Drug-Induced QT Interval Lengthening in Women |
Recruiting |
NCT03834883 |
Phase 4 |
Progesterone;Ibutilide |
3 |
Novel Form of Acquired Long QT Syndrome |
Recruiting |
NCT04169100 |
Phase 4 |
Prednisone |
4 |
Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery |
Recruiting |
NCT03893734 |
Phase 4 |
methadone;Hydromorphone |
5 |
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening |
Not yet recruiting |
NCT04675788 |
Phase 4 |
Progesterone;Ibutilide;Testosterone;Placebo |
6 |
A Phase 3, Single-Blind Study to Evaluate the Effect of Eleclazine (GS-6615) on Shortening of the QT Interval, Safety, and Tolerability in Subjects With Long QT Syndrome Type 3 |
Terminated |
NCT02300558 |
Phase 3 |
Eleclazine;Eleclazine placebo |
7 |
Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine |
Unknown status |
NCT01728025 |
Phase 2 |
Ranolazine |
8 |
ECG Device for Long QT Syndrome Screening in Newborns |
Unknown status |
NCT02412709 |
Phase 2 |
|
9 |
Ranolazine in LQT3 Patients |
Completed |
NCT01648205 |
Phase 2 |
Placebo;Ranolazine |
10 |
Influence of Progesterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes |
Completed |
NCT01929083 |
Phase 2 |
Progesterone;Placebo;Ibutilide |
11 |
Mutation-specific Therapy for the Long QT Syndrome |
Not yet recruiting |
NCT04581408 |
Phase 2 |
Lumacaftor / Ivacaftor, Orkambi® Oral Tablet |
12 |
A Double-center, Randomized, Double-blinded, 2-way Crossover, Placebo-controlled Study: Comparison of Single Oral Dose 400mg Moxifloxacin-induced QT Prolongation Between Healthy Chinese Volunteers and Caucasian Volunteers |
Unknown status |
NCT02119091 |
Phase 1 |
Moxifloxacin |
13 |
An Open-label Study to Evaluate the Effect of Single Dose GS-6615 on QT, Safety and Tolerability in Subjects With Long QT-3 Syndrome |
Completed |
NCT01849003 |
Phase 1 |
GS-6615 |
14 |
A Phase 1, Open-Label, Parallel-Group, Adaptive, Single Dose Study to Evaluate the Pharmacokinetics of GS-6615 in Subjects With Normal and Impaired Hepatic Function |
Completed |
NCT02412098 |
Phase 1 |
Eleclazine |
15 |
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Subjects |
Completed |
NCT02365532 |
Phase 1 |
GS-6615;Placebo to match GS-6615;Placebo to match dofetilide;Dofetilide |
16 |
A Phase 1 Open-Label, Parallel-Group, Adaptive, Single Dose Study to Evaluate the Pharmacokinetics of GS-6615 in Subjects With Normal and Impaired Renal Function |
Completed |
NCT02441829 |
Phase 1 |
Eleclazine |
17 |
A Randomized, Double-Blind, Placebo and Moxifloxacin (Open-Label) Controlled, 4-Period, Crossover Study of the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects |
Completed |
NCT00316459 |
Phase 1 |
ERB-041 |
18 |
Five Period Crossover Study of the Ability of Late Sodium or Calcium Current Block (Mexiletine, Lidocaine, or Diltiazem) to Balance the Electrocardiographic Effects of hERG Potassium Current Block (Dofetilide or Moxifloxacin) |
Completed |
NCT02308748 |
Phase 1 |
Dofetilide;Mexiletine;Lidocaine;Moxifloxacin;Diltiazem;Placebo |
19 |
A Double-blind, Placebo-controlled Study to Evaluate the Effect of GS-6615 on QT, Safety and Tolerability in Subjects With Long QT2 Syndrome |
Completed |
NCT02365506 |
Phase 1 |
Eleclazine;Placebo |
20 |
Comprehensive in Vitro Proarrhythmia Assay (CiPA) Clinical Phase 1 ECG Biomarker Validation Study (CiPA Phase 1 ECG Biomarker Study) |
Completed |
NCT03070470 |
Phase 1 |
Ranolazine;Verapamil;Lopinavir / Ritonavir;Chloroquine;Placebo;Dofetilide and Diltiazem |
21 |
Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients With KCNQ1 or KCNH2 Mutation Without Long QT Interval in Rest ECG |
Unknown status |
NCT01745666 |
|
|
22 |
Metabolism of Patients With Genetically Caused Cardiac Arrhythmia |
Unknown status |
NCT02775513 |
|
|
23 |
Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases |
Unknown status |
NCT00221832 |
|
|
24 |
Hydroxyzine and Risk of Prolongation of QT Interval |
Unknown status |
NCT02814981 |
|
|
25 |
QT-Prolongation in Lung Transplantation |
Unknown status |
NCT02380365 |
|
|
26 |
Prevelance of Fragmented QRS Complex and Prolonged QT Interval in Cirrhotic Patients and Its Correlation With the Severity of the Disease |
Unknown status |
NCT03158701 |
|
|
27 |
Exploring Mechanisms and Morphology of QT Interval Prolongation - An Inheritable as Well as an Inducible Phenomenon |
Completed |
NCT03291145 |
|
Beta Blockers;Spironolactone |
28 |
Prevalence of Congenital Long QT Syndrome and Acquired QT Prolongation in a Hospital Cohort |
Completed |
NCT03544918 |
|
|
29 |
Abnormal QT-Response to the Sudden Tachycardia Provoked by Standing in Individuals With Drug-induced Long QT Syndrome |
Completed |
NCT02581241 |
|
|
30 |
Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal Subjects |
Completed |
NCT00588965 |
|
Placebo;Propranolol LA |
31 |
The Effect of Pink Grapefruit Juice on the QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome |
Completed |
NCT02680080 |
|
Moxifloxacin |
32 |
Further Research on Human Feasibility of a Subcutaneous Implantable Defibrillator (S-ICD)- ECG Signal Collections From Various Patient Groups Whilst Attending Outpatient Follow-up |
Completed |
NCT00399412 |
|
|
33 |
The Long QT Syndrome in Pregnancy |
Completed |
NCT00488254 |
|
|
34 |
Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome |
Completed |
NCT01705925 |
|
|
35 |
National Long QT Syndrome Registry: Canadian Genetic Heart Rhythm Network |Research Data Registry and Bio Bank |
Completed |
NCT02425189 |
|
|
36 |
Obstructive Sleep Apnea and Cardiac Electrophysiologic Biomarkers of Sudden Cardiac Death |
Completed |
NCT03678311 |
|
|
37 |
Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital |
Completed |
NCT02068170 |
|
Haloperidol, azi/clari/erythromycin, levo/moxifloxacin, co-trimoxazole, vori/keto/flu/itraconazole, methadone, tacrolimus, sunitinib |
38 |
QT-prolongation in Psychiatric Hospitals |
Completed |
NCT02043925 |
|
drugs linked with QT-prolongation |
39 |
Drug Interactions With Risk of QT-prolongation in a General Hospital: an Epidemiological Point Prevalence Study |
Completed |
NCT02043912 |
|
Haloperidol |
40 |
Epidemiology of Long QTand Asian Sudden Death in Sleep |
Completed |
NCT00005367 |
|
|
41 |
Long QT & Hearing Loss Prospective Study Registry |
Completed |
NCT02082431 |
|
|
42 |
Azitromycin Use in COVID-19 Positive Pediatric Patients; Effect on Ventricle Repolarization |
Completed |
NCT04699097 |
|
Azithromycin |
43 |
Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER) |
Completed |
NCT00292032 |
|
|
44 |
Linkage Study of Long QT Syndrome In An Amish Kindred |
Completed |
NCT00005250 |
|
|
45 |
Long QT Syndrome-Population Genetics and Cardiac Studies |
Completed |
NCT00005176 |
|
|
46 |
Does Azithromycin Cause QT Prolongation in Hospitalized Patients With Severe Community Acquired Pneumonia? |
Completed |
NCT01553734 |
|
|
47 |
Fetal and Neonatal Magnetophysiology |
Completed |
NCT01903564 |
|
|
48 |
Modulation of QT Interval by Rapid Atrial Pacing in Patients With Dual Chamber Pacemakers |
Completed |
NCT00883610 |
|
|
49 |
Long Term Monitoring to Detect Risk of Sudden Death in Inherited Arrhythmia Patients |
Completed |
NCT04124237 |
|
|
50 |
Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies |
Completed |
NCT03182777 |
|
|
Cochrane evidence based reviews: long qt syndrome
|